The Endocrine Society Names Barbara Byrd Keenan as Chief Executive Officer

Chevy Chase, MD–The Endocrine Society is pleased to announce the selection of Barbara Byrd Keenan as the organization's next chief executive officer. Ms. Keenan brings more than two decades of impressive association management and leadership, with particular expertise in development, marketing, positioning and partnerships—all qualities that will help the Society accelerate its growth and impact. Ms. Keenan will assume her new role as CEO on Jan. 6, succeeding Scott Hunt, MBA, who is retiring after 25 years. 

"As we approach the start of our second century, the Society is actively seeking opportunities to grow in its capacity to lead including moving offices to downtown Washington, enhancing our programs and services, and intensifying our advocacy efforts," said Teresa K. Woodruff, Ph.D., president. "Ms. Keenan will be instrumental in helping the Society capitalize on its many strengths and continue moving forward."

Ms. Keenan currently is executive vice president of the Institute of Food Technologists and previously served as President of the Community Associations Institute. She also served on the board of directors for the American Society of Association Executives and is the recipient of numerous awards and recognitions.

"Endocrinologists are on the forefront of medicine and are addressing some of the most pressing health concerns of our day," Ms. Keenan noted. "I'm excited to join the Society's work and become part of its amazing team."

Founded in 1916, The Endocrine Society ( is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Its membership consists of more than 16,000 scientists, physicians, educators, nurses and students, who represent basic, applied and clinical interests in more than 100 countries. The Society has an operating budget of $30 million and The Washington Business Journal lists the Society as one of the 50 largest associations in Washington.

The Endocrine Society publishes five world-renowned journals and a monthly news magazine, conducts the premier international endocrine meeting as well as other educational and scientific conferences, provides educational programs for physicians, issues clinical practice guidelines, promotes careers in endocrinology, and advocates for appropriate funding of scientific research in endocrinology and public policies that support the practice of clinical endocrinology.

"The field of endocrinology is facing real challenges," Dr. Woodruff said. "Diabetes, obesity and metabolic conditions are harming the well-being of both children and adults and threatening to become a disease tsunami in many countries. Through its focus on scientific discovery, medical practice, and human health, the Endocrine Society is in a position to help solve such critical issues."

Ms. Keenan's skills and vision will be a catalyst for the Society's expanding agenda, which includes strategic partnerships to advance the field and facilitate research breakthroughs. 


Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology.  Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at!/EndoMedia.

Suggested Articles

Q32 Bio raised $60 million to push its lead antibody through the clinic and bolster its pipeline and the technology behind it.

Sanofi is teaming up with Merck while AstraZeneca taps Arcus as the future of cancer work is very much made together.

The action follows the FDA’s decision to reject a filing for approval of the JAK1 inhibitor in rheumatoid arthritis due to toxicity concerns.